Epidemiology of hepatocellular carcinoma in a rural area. Role of hepatotrophic viruses on survival;Epidemiología del carcinoma hepatocelular en un área rural. Papel de los virus hepatotropos en la supervivencia

Anales de Medicina Interna

Volumn 22, Issue 4, 2005, Pages 162-166

  Rodríguez Vidigal, Francisco Félix ^a   Baz, M J ^a   Romero, J ^a   Del Puerto, M ^a  

^a Hospital de Llerena   (Spain)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Survival

Indexed keywords

ADULT; AGE; AGED; ALCOHOL ABUSE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CHRONIC HEPATITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; RURAL AREA; SEX;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RURAL POPULATION; SPAIN;

EID: 19544385602     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Sermin Liver Dis 1999; 19: 271-86
2. Law MG, Roberts SK, Dore GJ, Kaldor JM. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust 2000; 173: 403-5
3. Parkin DM, Brey F, Ferlay J, Pirani P. Estimating the world cancer burden. Globocan 2000. Inf J Cancer 2001; 94: 153-6
4. El-Serag HB. Hepatocellular carcinoma and hepatitis C in United States. Hepatology 2002; 36 (Supl. 1): S74-83
5. ElSaadany S, Tepper M, Mao Y, Semenciw R, Giulivi A. An epidemiologic study of hepatocellular carcinoma in Canada. Can J Public Health 2002; 93: 443-6
6. Kiyosawa K, Tanaka E. Characteristics of hepatocellular carcinoma in Japan. Oncology 2002; 62 (Supl. 1): 5-7
7. Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Haussinger D. Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic. Z Gastroenterol 1997; 35: 1059-67
8. Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998; 29: 944-52
9. Okuda K. Hepatocellular carcinoma. J Hepatol 2000; 32 (Supl. 1): 225-237
10. Bosch FX, Ribes J. Epidemiology of liver cancer in Europe. Can J Gastroenterol 2000; 14: 621-30
11. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-24
12. Cuende N, Miranda B, Cañón JF, Naya T, Garrido G. Criterios de priorización para el acceso al trasplante. El caso del trasplante hepático en España. Med Clin (Barc) 2003; 120: 380-6
13. Llovet JM, Bustamante J, Castels A, Vilana R, Ayuso MC, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62-7
14. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-38
15. Tanizaki H, Ryu M, Kinoshita T, Kawano N, Konishi M, Cho A, et al. Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma. Jpn J Clin Oncol 1997; 27: 67-70
16. Ahmad SA, Bilimoria MM, Wang X, Izzo F, Delrio P, Marra P, et al. Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma. J Gastroenterol Surg 2001; 5: 468-76
17. Yanamaka T, Shiraki K, Nakazawa S, Okano H, Ito K, Deguchi M, et al. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Anticancer Res 2001; 21: 2937-40
18. Gelatti U, Donato F, Tagger A, Fantoni C, Portolani N, Ribero ML, et al. Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Am J Gastroenterol 2003; 98: 907-14
19. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001; 35: 421-30
20. Pugh RNH, Murria IM, Dawson JL, Pietroni MC, Willians R. Transection of the esophagus in Italy: a multicentric, controlled study. Hepato-Gastroenterol 1983; 30: 48-50.
21. Kleinbaum DG, Kupper LL, Chambless LE. Logistic regression analysis of epidemiological data. Theory and practice. Commun Statist Theory Methods 1982; 71: 485-547
22. Crespo J, Dueñas C, Sánchez-Antolín G, Fábrega E, Carte B, Pons-Romero F. Infección por el virus de la hepatitis C y C en pacientes con carcinoma hepatocelular. Med Clin (Barc) 1996; 106: 241-5
23. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000; 14: 703-9
24. Hellerbrand C, Hartmann a, Richter G, Knoll A, Wiest R, Scholmerich J, et al. Hepatocellular carcinoma in southern Germany: epidemiological and clinocopathological characteristics and risk farctors. Dig Dis 2001; 19: 345-51
25. Rodríguez-Vidigal FF, Baz MJ, Fernández FJ, Najarro F. Infección por el virus de la hepatitis C en un hospital de primer nivel de ámbito rural: estudio descriptivo en la década 1991-1999. Enf Infecc Microbiol Clin 2003; 21: 140-4
26. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17
27. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazzioti A, Morabito A, Torzilli G. No treatment, resection and etanol injection in hepatocellular carcinoma: a retrospective análisis of survival in 391 patients with cirrosis. J Hepatol 1995; 22: 522-6
28. Villa E, Moles A, Ferretti I, Buttafoco P, Grottola A, Del Bruno M, et al. Natural history of inoperable hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62-7.